Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2023-04-27 2023-06-09 190671
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2019-06-27 2019-08-29 87665
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2023-06-16 2023-08-18 195121
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2019-11-07 2020-05-29 98188
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2021-01-15 2021-05-06 131691
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2021-02-05 2021-04-29 133457
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2021-06-24 2021-07-09 141469
DOCETAXEL INJECTION 80MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1688
DOCETAXEL INJECTION 20MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1680
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-06-18 2020-06-25 118253
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-11-01 95381
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2025-01-30 2025-03-20 249213
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2023-06-20 2023-10-19 195806
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-01-20 2022-04-21 153156
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-02-17 2022-03-24 155155
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95378
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2023-06-16 2023-07-05 195219
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-01-09 2020-02-21 102893
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2025-01-30 2025-04-24 249210
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2018-06-22 2018-10-11 52823
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-RASAGILINE 1MG TABLET Reversed 2025-05-28 2025-06-04 258753
TEVA-RISEDRONATE 30MG TABLET Discontinued 2025-05-28 2025-05-28 258473
TEVA-RISEDRONATE 30MG TABLET Discontinued 2025-04-29 2025-04-29 256079
TEVA-RISEDRONATE 150MG TABLET Discontinued 2021-02-12 2021-02-12 133905
TEVA-RISPERIDONE 2MG TABLET Reversed 2025-05-28 2025-06-04 258679
TEVA-RISPERIDONE 3MG TABLET Reversed 2025-05-28 2025-06-04 258685
TEVA-RISPERIDONE 1MG TABLET Reversed 2025-05-28 2025-06-04 258673
TEVA-RISPERIDONE 0.25MG TABLET Reversed 2025-05-28 2025-06-04 258711
TEVA-RISPERIDONE 4MG TABLET Reversed 2025-05-28 2025-06-04 258688
TEVA-ROSUVASTATIN 20MG TABLET Reversed 2025-05-28 2025-06-04 258765
TEVA-ROSUVASTATIN 5MG TABLET Discontinued 2022-03-25 2022-03-26 157428
TEVA-ROSUVASTATIN 10MG TABLET Discontinued 2022-03-25 2022-03-26 157431
TEVA-ROSUVASTATIN 20MG TABLET Discontinued 2022-03-25 2022-03-26 157434
TEVA-ROSUVASTATIN 40MG TABLET Discontinued 2022-03-25 2022-03-26 157437
TEVA-SPIRONOLACTONE 100MG TABLET Discontinued 2025-05-28 2025-05-28 258486
TEVA-SUCRALFATE 1G TABLET Discontinued 2025-09-02 2025-09-02 266359
TEVA-TECNAL 330MG 40MG 50MG CAPSULE Discontinued 2025-05-28 2025-05-28 258478
TEVA-TECNAL 50MG 330MG 40MG TABLET Discontinued 2025-05-28 2025-05-28 258471
TEVA-TECNAL C 1/2 50MG 330MG 30MG 40MG CAPSULE Discontinued 2025-05-28 2025-05-28 258462